Jobs / United States / Astrazeneca Pharmaceuticals Lp
Senior Medical Science Liaison – Cell Therapy (New England)
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Boston - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles4 certified filings for “Associate Director, Precision Medicine” (Medical Scientists, Except Epidemiologists) in MA: $179k–$260k, median $215k. Most were filed at wage level II (75%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Senior Medical Science Liaison – Cell Therapy (New England) Do you have expertise in, and passion for Medical Affairs in Cell Therapy ? Are you ready to make a significant impact in the field of Multiple Myeloma ? AstraZeneca’s vision in Cell Therapy is to boldly transform the CAR-T experience with unwavering commitment to cure and access for every patient in need. Help to advance our pipeline by applying expertise and accelerating our pathway to finding a cure. We are seeking a Senior Medical Science Liaison (MSL) to join our Cell Therapy team in the territory of New England ! This role serves as the local medical voice of AZ in cell therapy and myeloma and will build a local medical strategy to improve patient care and outcomes in their territory. The MSL is an established field-based professional with extensive scientific, clinical, and therapeutic area expertise responsible for providing medical and scientific support for AstraZeneca's cell therapy assets. What you’ll do • Develop and maintain scientific relationships with hematology/cell therapy thought leaders, investigators and appropriate HCPs across academic and community centers within an assigned territory • Engage in scientific exchanges with the multidisciplinary team, including treating hematologists/oncologists, cell therapy physicians, APPs, pharmacists, apheresis and cell processing staff and nursing • Respond to unsolicited requests for scientific and product information in accordance with company policy • Establish oneself as a trusted scientific advisor, peer and expert to both internal stakeholders and external HCPs (e.g. functions as an expert in response to scientific questions) • Educate cell therapy provider teams on disease state, CAR-T mechanism of action, multiple myeloma therapeutic landscape, safety and clinical management, manufacturing processes and data pertaining to the infusion center and patient management, guided by compliance considerations • Support the implementation of cell therapy infusions in cell therapy infusion centers by timely support of health care providers in navigating the complexity of cell therapy and diverse stakeholder groups • Gather and synthesize site-level insights from site physician leadership, multiple HCP segments within the region and communicate with medical leadership and relevant internal partners • Identify data and educational gaps through discussion with External Scientific Experts (ESE) to inform medical affairs strategy and address unmet patient needs • Identify opportunities to partner with HCPs on disease state initiatives, collaborative research projects, and investigator sponsored research (ISR) of interest and in alignment with areas of scientific interest • Collaborate with key stakeholders across Medical Affairs, Commercial, and Research and Development (R&D) • Support and represent Medical Affairs at relevant congresses and scientific meetings through scientific exchange with ESEs, medical booth coverage and sharing scientific and competitive insights Minimum Qualifications • Advanced scientific degree required (i.e. PharmD, MD/DO, PhD, PA or NP) in a relevant health science or clinical discipline • 5+ years of experience in hematology/oncology with at least 2 years in a field medical or equivalent scientific engagement role, preferably in cell therapy and/or multiple myeloma • Ability to express ideas clearly in written documentation, one-on-one conversations and in small group dialogues with the ability to distill complexity down to key messages and scientific narrative for internal/external stakeholders • Experience supporting the development and/or launch of a new pharmaceutical product in the U.S. • Experience operating in a matrixed environment with cross-